Sorrento Therapeutics Inc
(SRNE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,755 | 9,639 | 5,091 | 6,445 | 7,625 |
| Receivables | 93 | 134 | 80 | 86 | 89 |
| TOTAL | $5,922 | $10,462 | $5,252 | $6,598 | $7,728 |
| Non-Current Assets | |||||
| PPE Net | 1,450 | 1,550 | 1,481 | 1,271 | 1,167 |
| Intangibles | 89 | 90 | 0 | 0 | 0 |
| Other Non-Current Assets | 328 | 97 | 49 | 23 | 23 |
| TOTAL | $1,866 | $1,737 | $1,530 | $1,293 | $1,190 |
| Total Assets | $7,789 | $12,198 | $6,782 | $7,892 | $8,917 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 292 | 268 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 736 | 707 | 440 | 395 | 276 |
| Accrued Expenses | 456 | 291 | 145 | 150 | 139 |
| TOTAL | $1,484 | $1,266 | $584 | $544 | $416 |
| Non-Current Liabilities | |||||
| Long Term Debt | 535 | 608 | N/A | N/A | N/A |
| TOTAL | $535 | $608 | $N/A | $N/A | $N/A |
| Total Liabilities | $2,019 | $1,874 | $584 | $544 | $416 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 16,502 | 336,076 | 336,076 | 300,030 | 299,877 |
| Common Shares | 1 | 34 | 1 | 30 | 30 |
| Retained earnings | -18,209 | -13,473 | -10,950 | -9,196 | -7,954 |
| TOTAL | $5,770 | $10,324 | $6,197 | $7,347 | $8,502 |
| Total Liabilities And Equity | $7,789 | $12,198 | $6,782 | $7,892 | $8,917 |